Outlook Therapeutics, Inc. (OTLK)
0.4882
-0.01
(-2.36%)
USD |
NASDAQ |
Oct 16, 16:00
0.4918
0.00 (0.00%)
After-Hours: 20:00
Outlook Therapeutics Price : 0.4882 for Oct. 16, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 0.52 | 0.5326 | 0.485 | 0.4882 | 3.117M |
| Oct 15, 2026 | 0.4881 | 0.5099 | 0.4379 | 0.50 | 5.350M |
| Oct 14, 2026 | 0.5571 | 0.5651 | 0.47 | 0.4702 | 9.642M |
| Oct 13, 2026 | 0.5788 | 0.5812 | 0.551 | 0.5638 | 3.251M |
| Oct 12, 2026 | 0.599 | 0.60 | 0.57 | 0.5851 | 2.310M |
| Oct 09, 2026 | 0.5675 | 0.605 | 0.5557 | 0.5989 | 3.685M |
| Oct 08, 2026 | 0.58 | 0.5898 | 0.5506 | 0.564 | 4.002M |
| Oct 07, 2026 | 0.6023 | 0.6066 | 0.58 | 0.59 | 4.235M |
| Oct 06, 2026 | 0.60 | 0.62 | 0.572 | 0.572 | 3.164M |
| Oct 05, 2026 | 0.60 | 0.6101 | 0.58 | 0.5955 | 4.688M |
| Oct 02, 2026 | 0.59 | 0.6067 | 0.5723 | 0.593 | 5.620M |
| Oct 01, 2026 | 0.58 | 0.5904 | 0.5314 | 0.575 | 7.069M |
| Sep 30, 2026 | 0.6257 | 0.6347 | 0.5729 | 0.5735 | 9.012M |
| Sep 29, 2026 | 0.63 | 0.6359 | 0.6118 | 0.6257 | 4.583M |
| Sep 28, 2026 | 0.63 | 0.6379 | 0.6005 | 0.6211 | 6.098M |
| Sep 25, 2026 | 0.6551 | 0.6705 | 0.636 | 0.6395 | 2.936M |
| Sep 24, 2026 | 0.66 | 0.6798 | 0.6411 | 0.6558 | 2.780M |
| Sep 23, 2026 | 0.7045 | 0.7045 | 0.6616 | 0.6617 | 2.932M |
| Sep 22, 2026 | 0.6863 | 0.7137 | 0.6766 | 0.6962 | 2.864M |
| Sep 21, 2026 | 0.6853 | 0.695 | 0.6527 | 0.6863 | 2.878M |
| Sep 18, 2026 | 0.70 | 0.70 | 0.6526 | 0.6526 | 5.622M |
| Sep 17, 2026 | 0.6952 | 0.71 | 0.6775 | 0.681 | 2.810M |
| Sep 16, 2026 | 0.675 | 0.7361 | 0.662 | 0.6769 | 7.315M |
| Sep 15, 2026 | 0.64 | 0.6820 | 0.6253 | 0.673 | 4.517M |
| Sep 14, 2026 | 0.6543 | 0.6688 | 0.6316 | 0.6379 | 2.848M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Valion Bio, Inc. | 1.17 |
| Agenus, Inc. | 6.04 |
| Amgen, Inc. | 432.49 |
| Anika Therapeutics, Inc. | 19.98 |
| BioCryst Pharmaceuticals, Inc. | 7.79 |
Price Related Metrics
| PS Ratio | 88.87 |
| Earnings Yield | -231.7% |
| Market Cap | 91.34M |